TAK

#478
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
17.7800 USD
-0.48%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
17.7700
17.8100
Range Annuel
12.9900
18.8950
Changement quotidien
-0.48%
Changement Mensuel
-3.47%
Evolution sur 6 mois
+25.34%
Changement Annuel
+25.34%
Clôture Précédente
17.8650
Open
17.8000
Bid
Ask
Low
17.7700
High
17.8100
Volume
91
Open full chart

Financials

Overview Relevé Statistics Dividends
Quarterly Annual
  • Market Capitalization 27.6971 B
  • Employee 47 K
  • Founded N/A
  • CEO Christophe WeberChristophe Weber
  • Website www.takeda.com
  • Headquarter Japan
  • FIGI BBG000LF8708
  • Industry Fabricants de Médicaments — Spécialités et Génériques

Takeda Pharmaceutical Company Limited American Depositary Share

The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda.

Nouvelles